Argus Research Maintains Buy on Cardinal Health, Raises Price Target to $309
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.
Last updated: 2026-11-13 12:49:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cardinal Health, Inc. (CAH) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NYSE. The stock is currently priced at $278.19, with a market capitalization of $64.29B and a P/E ratio of 35.36. Over the past 52 weeks, its price has ranged from $180.45 to $286.29. This page covers its latest market performance, valuation, price trends and company information.
$64.29B | |
$278.02 | |
$279.43 | |
$278.02 | |
$278.14 | |
646.00 | |
1.69M | |
35.36 | |
$286.29 | |
$180.45 | |
0.76% | |
06-30 |
Cardinal Health, Inc. (CAH) is trading at $278.19 in pre-market trading as of 2026-11-13 12:31:13, up 0.02% ($0.05) from the previous close of $278.14
Pre-market trading shows how investors are pricing CAH before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Cardinal Health, Inc. (CAH) moved from $267.82 to $278.19, representing a gain of 3.87% ($10.37).
The stock traded between $263.92 and $286.29 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.46 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 92.3%
CAH is currently trading at $278.19, placing it 92.3% of the way from its 52-week low of $180.45 to its 52-week high of $286.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Employees | 63,900 |
| CEO | Jason M. Hollar |
| Founded | 1979 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Cardinal Health, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Jan 4, 2027 |
| Payment Date | Jan 15, 2027 |
| Dividend Per Share | $0.5158 |
Latest news related to Cardinal Health, Inc. and CAH stock.
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.
Cardinal Health (CAH) is highlighted as a momentum investment pick with a Zacks Rank #2 (Buy) and Momentum Style Score of B. The stock has outperformed its industry with 8.48% weekly gains and 35.15% annual returns, while recent earnings estimate revisions have moved higher, supporting its bullish outlook.
Eligible investors can buy real shares of Cardinal Health, Inc. (CAH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CAH, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CAH shares and USD.
CAH Shares to USD
1.00 CAH shares = 278.185 USD
Calculations are estimates based on the latest available price and are for reference only.